Lochmüller Lab

Brenda is responsible for coordinating Dr. Lochmüller’s Neuromuscular clinic at The Ottawa Hospital and occasionally at CHEO. 

Liz is a clinical research coordinator at the Ottawa Hospital Research Institute – Neuromuscular Department supporting multiple phase II-IV clinical studies on rare neuromuscular diseases with Dr. Lochmuller.

In October 2019, Isabelle started to work as a clinical evaluator for the various neuromuscular disease trials with Dr. Hanns Lochmüller at CHEO and The Ottawa Hospital. In February 2022, she joined The Ottawa Hospital as a clinical research coordinator.

Emily is a Post-Doctoral fellow in the Lochmüller Lab, where she hopes to use patient-derived stem cells to discover new drug therapies for myotonic dystrophy. Emily completed her PhD from the University of Ottawa under the supervision of Dr. Kyle Cowan at the Children’s Hospital of Eastern Ontario. Here she discovered a sex-dependant role for the small molecule channel Pannexin 1 in healthy skeletal muscle and found it to be a novel therapeutic target for Duchenne muscular dystrophy.

Abbie worked in the Lochmüller lab as a Research Technician in 2020.

Jian-Jun has worked in Ottawa for many years and worked in the Lochmüller lab as a research assistant.

Danny is currently a second-year medical student at Queen’s University and is joining the Lochmüller Lab as a summer research student for summer 2020 for a bioinformatics-focused project investigating pediatric CMS patients without a molecular diagnosis.

Matthew joined the team in June 2021 as a Research Coordinator, working on several neuromuscular disease clinical trials for Dr. Lochmüller.

Miriam received a BSc Hons. in Biology (Concentration Physiology) in 2021 from Carleton University. Miriam Joined the Lochmuller clinical research team in November 2022 as a research assistant, having worked as a medical assistant at a family practice before joining the team.

Following the completion of his Masters degree, Alex started studying Medicine at the University of Ottawa. He has joined the Lochmüller lab to work on a project investigating the therapeutic potential of Smac-mimetic compounds on neuromuscular diseases.

Emily completed her PhD at Newcastle University in 2019 under the supervision of Professors Hanns Lochmüller and Clarke Slater and joined the Lochmüller lab to continue her work into testing new treatments for CMS.

Kaitlyn Quinlan has just completed her second undergraduate year in Neuroscience and Mental Health at Carleton University and is joined the Lochmüller lab for summer 2019.

Rosa joined the Lochmüller Lab in 2019 to contribute to the group’s clinical research activities.

Rohan Ray is a 4th year student in Translational and Molecular Medicine.

Anu is a post-doctoral fellow working on gene therapy for congenital myasthenic syndromes (CMS) and on biomarkers for myotonic dystrophy type 1 (DM1).